# electroCore (ECOR) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ECOR
## Company Profile
- Ticker: ECOR
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: CNS
## Stock Data
- Close: 9.4 USD
- Market cap: 78394431.14999999 USD
- Last updated: 2026-08-12
## Business Overview
### Noninvasive Neuromodulation
electroCore develops handheld bioelectronic devices that stimulate the vagus nerve without surgery. Its products are used across prescription and consumer channels.
### gammaCore
gammaCore is a prescription noninvasive vagus-nerve-stimulation device used for headache disorders. A major commercial channel is the U.S. Department of Veterans Affairs.
### Quell and Truvaga
The Quell franchise addresses fibromyalgia and chronic pain through wearable neurostimulation, while Truvaga is marketed directly to consumers for wellness applications.
### Clinical Expansion
electroCore is also supporting studies of gammaCore in additional neuropsychiatric settings, including adjunctive treatment of post-traumatic-stress symptoms.
## Why The Stock Is Moving

As of Aug 12, 2026, ECOR closed up 3.07% at $9.40. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-06 20:05 EST — [electroCore Announces Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ECOR/electrocore-announces-second-quarter-2026-financial-results-08dfc7f0) — Source: electroCore
- 2026-08-03 12:00 EST — [electroCore to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ECOR/electrocore-to-participate-in-upcoming-investor-conferences-3d1a9bbe) — Source: electroCore
- 2026-07-30 12:00 EST — [electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026](https://biopharmsignal.com/news/ECOR/electrocore-to-announce-second-quarter-june-30-2026-financial-results-on-thursda-1b5a79de) — Source: electroCore
- 2026-07-16 12:00 EST — [New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation](https://biopharmsignal.com/news/ECOR/new-review-examines-anatomical-and-methodological-differences-between-auricular--75858401) — Source: electroCore
- 2026-06-17 12:00 EST — [electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference](https://biopharmsignal.com/news/ECOR/electrocore-to-participate-in-iaccess-alpha-virtual-best-ideas-summer-investment-07437969) — Source: electroCore